Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Regenerative medical devices company Tissue Regenix Group said chief executive Steve Couldwell would return to full time duties during June.
Couldwell had taken a leave earlier this year to undergo medical treatment.
'The board and I look forward to welcoming Steve back into the full time CEO position and are grateful for his ongoing commitment,' chairman John Samuel said.
'During his necessary absence Steve remained in daily contact with the business and continued to be integral to implementing the business strategy and establishing future business developments, along with the support of Gareth Jones who undertook the chief operating officer role during this period.'
'The business has continued to develop in line with the board expectations.'
At 8:25am: (LON:TRX) Tissue Regenix Group PLC share price was -0.13p at 5.95p